Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials

BACKGROUND: Antipsychotic drugs and especially the newer compounds are known to cause metabolic side effects. However, a comprehensive comparison of the different substances regarding their propensity to cause metabolic side effects in medium- to long-term treatment of schizophrenia is lacking. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider-Thoma, Johannes, Kapfhammer, Angelika, Wang, Dongfang, Bighelli, Irene, Siafis, Spyridon, Wu, Hui, Hansen, Wulf-Peter, Davis, John M., Salanti, Georgia, Leucht, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330017/
https://www.ncbi.nlm.nih.gov/pubmed/34340713
http://dx.doi.org/10.1186/s13643-021-01760-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330017/
https://www.ncbi.nlm.nih.gov/pubmed/34340713
http://dx.doi.org/10.1186/s13643-021-01760-z

Ejemplares similares